ArticleMolecular oncology2025

CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compounds.

Sandra Amarilla-Quintana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.